Showing results (211-220 of 233) with videos related to
Sort By:
Pageof 24
Annals of Intensive Care|May 25, 2026
The IMPACT framework for evaluating generative AI in critical care: development and multinational consensus validationYu-Chang Yeh, Ming-Chieh Shih, Daniel De Backer, et al.Journal of Intensive Care|March 5, 2019
Physician agreement on the diagnosis of sepsis in the intensive care unit: estimation of concordance and analysis of underlying factors in a multicenter cohortBert K Lopansri, Russell R Miller Iii, John P Burke, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: VilobelimabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical IllnessAdarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, et al.Cell Reports Methods|May 9, 2022
Don't forget about human factors: Lessons learned from COVID-19 point-of-care testingSarah Farmer, Victoria Razin, Amanda Foster Peagler, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: InfliximabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.Nature|August 31, 2022
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19Matthew C Woodruff, Richard P Ramonell, Natalie S Haddad, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in AdultsAmy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo, et al.JAMA|October 2, 2019
Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical TrialAlpha A Fowler, Jonathon D Truwit, R Duncan Hite, et al.Pageof 24